Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2002 Jan 22;99(2):775-9.
doi: 10.1073/pnas.022523499. Epub 2002 Jan 15.

APH-1 is a multipass membrane protein essential for the Notch signaling pathway in Caenorhabditis elegans embryos

Affiliations

APH-1 is a multipass membrane protein essential for the Notch signaling pathway in Caenorhabditis elegans embryos

Caroline Goutte et al. Proc Natl Acad Sci U S A. .

Abstract

Early embryonic cells in Caenorhabditis elegans embryos interact through a signaling pathway closely related to the Notch signaling pathway in Drosophila and vertebrates. Components of this pathway include a ligand, receptor, the presenilin proteins, and a novel protein, APH-2, that is related to the Nicastrin protein in humans. Here we identify the aph-1 gene as a new component of the Notch pathway in Caenorhabditis elegans. aph-1 is predicted to encode a novel, highly conserved multipass membrane protein. We show that aph-1 and the presenilin genes share a similar function in that they are both required for proper cell-surface localization of APH-2/Nicastrin.

PubMed Disclaimer

Figures

Figure 1
Figure 1
aph-1 and wild-type embryos. (a) Living wild-type embryo viewed by light microscopy; the arrow indicates the anterior half of the pharynx and the arrowhead indicates the posterior half. (b) Immunostaining of pharyngeal cells; markers as in a. (c) Hypodermal cell boundaries delineated by green fluorescent protein expression; 10 cells are visible in the lateral row. (d) Four-cell embryo showing expression of the ligand APX-1. APX-1 is visible in the posterior-most cell (P2; white arrowhead) as a line contacting one of the GLP-1-expressing cells (ABp; black arrowhead); embryos oriented with the anterior to the left. (eh) aph-1 mutant embryos staged, prepared, and labeled as above. Note the extra hypodermal cells at the first, second, and fourth positions in g. e and g are aph-1(zu147), and f and h are aph-1(zu123).
Figure 2
Figure 2
(a) alignment of the predicted APH-1 protein of C. elegans with related proteins in Drosophila (33% identity, GenBank accession no. AAF51212) and humans (33% and 34% identity, GenBank accession nos. AAD34072 and AL136671, respectively). Each of the two human genes also has a highly related mouse gene, which is not shown here (GenBank accession nos. AC015932.1 and AK002310). Identical amino acids are black and conserved amino acids are gray; predicted transmembrane domains are overlined. Asterisks correspond to positions of aph-1 mutations as follows. zu123, Met to Ile; or28, Gly to Asp; zu147, Arg to opal stop codon. (b) APH-1 hydrophobicity plots (21); alignments as shown in a; predicted membrane-spanning regions are numbered above the plots.
Figure 3
Figure 3
GLP-1 and APH-2 localization in 4-cell stage embryos. The signaling cell (P2; white arrowhead) and responding cell (ABp; black arrowhead) are indicated in all panels. (a) Immunostaining of GLP-1 in wild type. GLP-1 is expressed on the surface of the anterior-most cell (Left) and its sister (black arrowhead). (b) Immunostaining of APH-2 in wild type. APH-2 is visible on the surface membranes of all four cells. (c and d) aph-1(zu123) embryos labeled as above. (e and f) Embryos deficient in presenilins [sel-12(ty11); hop-1(RNAi)] labeled as above. The level of APH-2 immunostaining is highest when cells are mid-interphase; in the images shown, the GLP-1-expressing cells appear to express a higher level of APH-2 because they are slightly more advanced in the cell cycle than the other two cells.

References

    1. Artavanis-Tsakonas S, Rand M D, Lake R J. Science. 1999;284:770–776. - PubMed
    1. Greenwald I. Genes Dev. 1998;12:1751–1762. - PubMed
    1. Kimble J, Simpson P. Annu Rev Cell Dev Biol. 1997;13:333–361. - PubMed
    1. Kopan R, Goate A. Genes Dev. 2000;14:2799–2806. - PubMed
    1. Yu G, Nishimura M, Arawaka S, Levitan D, Zhang L, Tandon A, Song Y Q, Rogaeva E, Chen F, Kawarai T, et al. Nature (London) 2000;407:48–54. - PubMed

Publication types

MeSH terms